JP2009519212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519212A5 JP2009519212A5 JP2008537892A JP2008537892A JP2009519212A5 JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5 JP 2008537892 A JP2008537892 A JP 2008537892A JP 2008537892 A JP2008537892 A JP 2008537892A JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- ome
- hsdavfteqy
- seq
- peg20k
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73029105P | 2005-10-26 | 2005-10-26 | |
| US74034205P | 2005-11-29 | 2005-11-29 | |
| US74336406P | 2006-02-28 | 2006-02-28 | |
| PCT/US2006/041550 WO2007050651A1 (en) | 2005-10-26 | 2006-10-24 | Selective vpac2 receptor peptide agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009519212A JP2009519212A (ja) | 2009-05-14 |
| JP2009519212A5 true JP2009519212A5 (https=) | 2009-12-17 |
Family
ID=37716005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008537892A Pending JP2009519212A (ja) | 2005-10-26 | 2006-10-24 | 選択的ｖｐａｃ２受容体ペプチドアゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7582608B2 (https=) |
| EP (1) | EP1942941A1 (https=) |
| JP (1) | JP2009519212A (https=) |
| KR (1) | KR101057284B1 (https=) |
| CN (1) | CN101296708B (https=) |
| AU (1) | AU2006306236B2 (https=) |
| BR (1) | BRPI0617740A2 (https=) |
| CA (1) | CA2627716A1 (https=) |
| EA (1) | EA012930B1 (https=) |
| IL (1) | IL189922A0 (https=) |
| NO (1) | NO20082345L (https=) |
| WO (1) | WO2007050651A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10328316A1 (de) | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| EP1781695A1 (en) * | 2004-08-18 | 2007-05-09 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| US7595294B2 (en) | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
| US20090170775A1 (en) * | 2004-10-08 | 2009-07-02 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide compositions |
| DE102005052588A1 (de) * | 2005-11-02 | 2007-05-10 | Grünenthal GmbH | Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| TWI496762B (zh) | 2006-07-24 | 2015-08-21 | 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法 | |
| EP3412300A1 (en) | 2008-06-27 | 2018-12-12 | Duke University | Therapeutic agents comprising elastin-like peptides |
| DK3311828T3 (da) * | 2009-08-14 | 2021-06-28 | Phasebio Pharmaceuticals Inc | Modificerede vasoaktive tarmpeptider |
| KR20120118008A (ko) * | 2009-12-18 | 2012-10-25 | 아이데닉스 파마슈티칼스, 인코포레이티드 | 5,5-융합 아릴렌 또는 헤테로아릴렌 간염 ｃ 바이러스 억제제 |
| WO2012170524A1 (en) | 2011-06-06 | 2012-12-13 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
| WO2015172046A1 (en) | 2014-05-08 | 2015-11-12 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
| CA2976038A1 (en) | 2015-02-09 | 2016-08-18 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating muscle disease and disorders |
| EP4137502A4 (en) * | 2020-03-30 | 2024-02-28 | Ichimaru Pharcos Co., Ltd. | Vipr2 antagonist peptide |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04193896A (ja) * | 1989-10-26 | 1992-07-13 | Meiji Seika Kaisha Ltd | 活性ペプチド |
| JPH0692991A (ja) * | 1991-02-28 | 1994-04-05 | Daicel Chem Ind Ltd | 新規活性ペプチド |
| WO1998002453A2 (en) | 1996-07-15 | 1998-01-22 | Universite Libre De Bruxelles | Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| HUP0104934A3 (en) | 1998-07-20 | 2002-05-28 | Sod Conseils Rech Applic | Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use |
| US6242563B1 (en) | 1998-07-20 | 2001-06-05 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Peptide analogues |
| US20030087820A1 (en) * | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
| JP2002544127A (ja) | 1999-04-30 | 2002-12-24 | アミリン・ファーマシューティカルズ，インコーポレイテッド | 修飾されたエキセンジンおよびエキセンジン・アゴニスト |
| RU2269354C2 (ru) | 1999-09-28 | 2006-02-10 | Байер Корпорейшн | Агонисты рецептора-3(r3) пептида-активатора гипофизарной аденилатциклазы(расар) и способы их фармакологического применения |
| MXPA04006679A (es) | 2002-01-08 | 2004-11-10 | Lilly Co Eli | Analogos extendidos de peptido-1 de tipo glucagon. |
| HN2003000217A (es) * | 2002-07-12 | 2004-07-26 | Bayer Pharmaceuticals Corp | Agonistas del receptor (vpac2) del peptido activamente de la adenilato ciclasa hipofisiaria (pacap) y sus metodos de uso farmacologico. |
| EP1605897B1 (en) * | 2003-03-19 | 2012-07-25 | Eli Lilly And Company | Polyethelene glycol link glp-1 compounds |
| MXPA06006745A (es) * | 2003-12-18 | 2006-08-18 | Novo Nordisk As | Compuestos glp-1 novedosos. |
| AU2005208911A1 (en) * | 2004-01-27 | 2005-08-11 | Bayer Healthcare Llc | Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| DE602005010578D1 (de) * | 2004-05-21 | 2008-12-04 | Lilly Co Eli | Selektive peptidische agonisten des vpac2-rezeptors |
| CA2567635A1 (en) * | 2004-05-21 | 2005-12-01 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| EP1781695A1 (en) * | 2004-08-18 | 2007-05-09 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| WO2008043102A2 (en) | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
| US7595294B2 (en) | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
| AU2005294125A1 (en) | 2004-10-08 | 2006-04-20 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
-
2006
- 2006-10-24 BR BRPI0617740-9A patent/BRPI0617740A2/pt not_active IP Right Cessation
- 2006-10-24 AU AU2006306236A patent/AU2006306236B2/en not_active Expired - Fee Related
- 2006-10-24 JP JP2008537892A patent/JP2009519212A/ja active Pending
- 2006-10-24 US US12/090,656 patent/US7582608B2/en not_active Expired - Fee Related
- 2006-10-24 KR KR1020087010055A patent/KR101057284B1/ko not_active Expired - Fee Related
- 2006-10-24 CN CN2006800398953A patent/CN101296708B/zh not_active Expired - Fee Related
- 2006-10-24 CA CA002627716A patent/CA2627716A1/en not_active Abandoned
- 2006-10-24 EA EA200801180A patent/EA012930B1/ru not_active IP Right Cessation
- 2006-10-24 WO PCT/US2006/041550 patent/WO2007050651A1/en not_active Ceased
- 2006-10-24 EP EP06817361A patent/EP1942941A1/en not_active Withdrawn
-
2008
- 2008-03-04 IL IL189922A patent/IL189922A0/en unknown
- 2008-05-23 NO NO20082345A patent/NO20082345L/no not_active Application Discontinuation
-
2009
- 2009-07-24 US US12/508,584 patent/US7897573B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009519212A5 (https=) | ||
| CN110229216B (zh) | 具有改善的药代动力学性质的坎普他汀类肽 | |
| EP2424557B1 (en) | Modified compstatin with peptide backbone and c-terminal modifications | |
| KR102812908B1 (ko) | 인크레틴 유사체의 제조 방법 | |
| EP2331567A1 (en) | Peptidomimetic macrocycles | |
| CN102171243A (zh) | N-端修饰的葡萄糖依赖性促胰岛素多肽(gip)类似物 | |
| CN115925790A (zh) | 用于合成α4β7肽拮抗剂的方法 | |
| JP2006525288A5 (https=) | ||
| WO2017023933A2 (en) | Peptidomimetic macrocycles | |
| CA2594423A1 (en) | Peptides with neuropeptide-2 receptor (y2r) agonist activity | |
| KR20110097807A (ko) | 뉴로펩티드-2-수용체(ｙ-2ｒ) 작용제 및 이의 용도 | |
| CN101437836B (zh) | 肽的硫酯化合物的制造方法 | |
| JP2005516996A5 (https=) | ||
| AU2006306236B2 (en) | Selective VPAC2 receptor peptide agonists | |
| CN109134610B (zh) | 一种肽类化合物、其应用及含其的组合物 | |
| CA2584805C (en) | Peptide anti-tumor agent | |
| WO2007021498A1 (en) | Selective vpac2 receptor peptide agonists | |
| CN114539358B (zh) | 一种多肽及制备方法与应用 | |
| JPWO2022096736A5 (https=) | ||
| WO2026009243A1 (en) | An improved process for the preparation of tirzepatide by using hybrid approach | |
| WO2025052429A1 (en) | An improved process for the preparation of tirzepatide | |
| HK40112064A (zh) | Crf2受体激动剂及其在治疗中的用途 | |
| CN121285571A (zh) | Glp-1/gip双重、glp-1/gcg双重和glp-1/gip/gcg三重受体激动剂 | |
| HU211694A9 (en) | Hexapeptides with sulphate ester groups | |
| Human | iolo ical e affilation of ne ar inine ao re in P analo e containin non nat ral a ino acid |